Ahn, Y. H., Kim, S. H., Han, K. H., Choi, H. J., Cho, H., Lee, J. W., . . . Kang, H. G. (2018). Efficacy and safety of rituximab in childhood-onset, difficult-to-treat nephrotic syndrome: A multicenter open-label trial in Korea. Medicine (Baltimore).
Citação norma ChicagoAhn, Yo Han, et al. "Efficacy and Safety of Rituximab in Childhood-onset, Difficult-to-treat Nephrotic Syndrome: A Multicenter Open-label Trial in Korea." Medicine (Baltimore) 2018.
MLA citiranjeAhn, Yo Han, et al. "Efficacy and Safety of Rituximab in Childhood-onset, Difficult-to-treat Nephrotic Syndrome: A Multicenter Open-label Trial in Korea." Medicine (Baltimore) 2018.
Opozorilo: Ti citati niso vedno 100% točni.